Concepedia

John R. Murren

JR

38

Publications

1.7K

Citations

23

H-Index

1991

Active since

Affiliations

Yale University(Current)

Yale Cancer Center

VA Connecticut Research and Education Foundation

Arizona Research Center

Memorial Sloan Kettering Cancer Center

John R. Murren is an author at Yale University specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

1991–2010

38

Publications

38

Phase II Study of Cisplatin Plus Etoposide and Bevacizumab for Previously Untreated, Extensive-Stage Small-Cell Lung Cancer: Eastern Cooperative Oncology Group Study E3501

Leora Horn, Suzanne E. Dahlberg, Alan B. Sandler et al. · Journal of Clinical Oncology · 2009 · 150 citations · Full text

Phase I Study of Inhaled Doxorubicin for Patients with Metastatic Tumors to the Lungs

Gregory A. Otterson, Miguel A. Villalona‐Calero, Sunil Sharma et al. · Clinical Cancer Research · 2007 · 129 citations

Staging and clinical prognostic factors for small-cell lung cancer.

Athanassios Argiris, John R. Murren · PubMed · 2002 · 112 citations

, , +16

Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors.

John R. Murren, Manuel Modiano, Caroline Clairmont et al. · PubMed · 2003 · 107 citations

Phase I/II Study of Inhaled Doxorubicin Combined with Platinum-Based Therapy for Advanced Non–Small Cell Lung Cancer

Gregory A. Otterson, Miguel A. Villalona‐Calero, William J. Hicks et al. · Clinical Cancer Research · 2010 · 106 citations · Full text

Rows per page

1–5 of 38